TrialSite’s had a great couple of years of providing breaking news, analysis, and insight into the fascinating, dynamic, and at times, frustrating world of clinical trials. We have purposely kept advertisements out of the site not only for ease of use and an appealing experience for our readers but also to maintain independence. Now, TrialSite’s evolving to the next level of its journey, moving to a novel, tiered subscription model.
Soon TrialSite will request that readers enjoying this media platform on a daily basis contribute to the ongoing growth of the company. Why? Because we will expand our staff in editorial, research, and analyses to provide even more cutting-edge coverage of the world of biomedical research, with an aim of driving even more transparency and accessibility to clinical trials.
Already we have developed a novel platform—part media, part social network, and part information hub—covering the gambit of activity in a clinical trial with an emphasis on the trial sites that conduct research, such as academic medical centers, research institutes, and commercial trial site organizations. As we move from a founder-subsidized model to one that’s sustained by member subscribers, we will produce even more compelling, original, and investigative content, research, and insights for ever more people.
TrialSite’s passed the 1 million readers-per-month mark with no marketing or extensive social network activity. With our new honor system-based model, we can maintain independence while sparing our readers intrusive advertisers. Our readership spans the world, from North America to Europe, Asia, Africa, and South America to Australia and Oceania.
TrialSite is grateful for our community members, which span the globe, and we now introduce a tiered subscription service to produce ever more compelling content. No media platform covers global clinical research like TrialSite.
Again, our subscription tiers use the “honor system.” This means that for those that don’t have the financial means or wherewithal, simply declare this but don’t abuse it. All of our tiers of service provide the same level of access to content. We are grateful for all of you, and we hope that you reciprocate.
Our new subscription tiers:
For anyone that cannot afford one of the other subscription tiers. For example: students, disabled veterans, people on disability or government assistant, retirees on a low retirement plan.
Note, this service is very free but just as valuable!
Individuals at home that are reading the TrialSite content for personal health care or other non-professional reasons.
$5 per month
Like a Starbucks a month!
$12 per month
More than a Starbucks coffee—but better!
TrialSite has hundreds of thousands of professional readers. This includes individuals employed at health systems, hospitals, pharmaceutical companies, government agencies, and investment houses as well as clinical trial service vendors such as contract research organizations and consulting firms.
Support our independent, objective media platform—become a subscribing member, and help take TrialSite to the next level of path-breaking efforts.